Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A double blind, placebo-controlled, multi-centre study to evaluate the efficacy, safety, tolerability and immunogenicity of repeated s.c administrations of 100µg NIC002 vaccine in cigarette smokers who are motivated to quit smoking https://www.kusajili.com:443/Trial/-yijkjhyaUusGo6trm-X2w%24a-double-blind-placebo-controlled-multi-centre-study-to-evaluate-the-efficacy-safety-tolerability-and-immunogenicity-of-repeate
I have read and accept the terms of use of the site and the Privacy Policy
Send your message